Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnolia Study
2014-002494-12Phase 4Completed
- Sponsor
- University Hospital Odense
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of zoledronic acid in multiple myeloma (MM) (2 arms), sponsored by University Hospital Odense. Primary endpoint: Time to progressive bone disease from year 2 to year 4. Started Oct 2014; status: completed.
02
Drugs
zoledronic acid
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2014-002494-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002494-12.